Medicine crossed a line in 2026. The FDA cleared UpDoc, the first patient-facing clinical large language model, under 510(k) clearance K253281, for insulin management in type-2 diabetes. For the first time, a regulator authorized a language model to speak directly with a patient rather than only assist a clinician behind the scenes.
The money followed fast. UpDoc raised 18 million dollars in seed funding, xCures raised 46 million dollars, and Trase raised 107 million dollars. That is more than 150 million dollars of fresh venture funding flowing into regulated healthcare AI in a matter of weeks.
Washington restructured around it. The FDA reviews medical devices through 8 Offices of Health Technology, with radiology among them, and a new voluntary Medicare pathway, the CMS ACCESS model paired with the FDA TEMPO pilot, opens in 2026. The scale is already large: 1,524 AI-enabled devices cleared, 1,163 of them in radiology (about 76 percent), roughly 30 new clearances every month, and 68 new radiology algorithms in the first quarter of 2026 alone.
A cleared patient-facing model proves that regulated, voice-first clinical AI is now shippable. It is the same lane we build at PATech with SkyAria, a voice AI that answers the calls a short-staffed clinic cannot. SkyAria is HIPAA-ready and makes no diagnostic claims; its job is time and access, not medicine. Watch the breakdown above, and follow the linked sources below.
Sources
FDA 510(k) clearance K253281 - U.S. Food and Drug Administration
Interested in implementing similar AI solutions? Discover how PATech Labs can help your business leverage cutting-edge artificial intelligence.
Learn About Our ServicesUpDoc debuts the first FDA-cleared patient-facing clinical LLM - HLTH
Trase secures 107M, xCures lands 46M - Fierce Healthcare
xCures lands 46M Series B - Crunchbase News
FDA launches the TEMPO pilot with the CMS ACCESS model - U.S. Food and Drug Administration
FDA numbers show 1,524 AI devices, radiology keeps its lead - The Imaging Wire